Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New support program aims to boost CPAP use in stroke rehab

NCT ID NCT06722755

Symptom relief Sponsor: University of Washington Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Aug 14, 2026 · Updated 3 times

Summary

This study tests whether extra support—like personalized mask fitting, monthly phone calls, and a tracking app—helps stroke patients with sleep apnea use their CPAP machine more consistently during rehab. About 250 participants will be randomly assigned to either this intensive support or standard care. The goal is to see if better CPAP use leads to improved stroke recovery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
CPAP device and behavioral support program
What this could lead to
If successful, this program could help stroke patients with sleep apnea use CPAP more regularly, potentially improving their recovery and daily function.
What could go wrong
This is a mid-stage trial with 250 participants, so results may not apply to all stroke patients. The intervention is behavioral, so individual motivation and comfort with CPAP may limit effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 250 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2025

Expected to finish

May 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria include: 1. Age 18 years or older 2. Head CT or brain MRI demonstrating an acute ischemic infarction or intraparenchymal hemorrhage within past 30 days 3. Person providing consent (patient or legally authorized representative (LAR)) able to be consented in English or Spanish. Exclusion criteria include: 1. Unable to obtain informed consent from participant or LAR in English or Spanish 2. Incarcerated 3. Known pregnancy-determined by reviewing clinical data 4. Current mechanical ventilation, tracheostomy, or supplemental oxygen use \> 4L/min 5. Use of positive airway pressure within 14 days prior to stroke 6. History of pneumothorax, bullous emphysema or other serious co-morbid conditions which limit CPAP use 7. Stroke related to tumors, vascular malformations or subarachnoid hemorrhage 8. Active use of sedative drugs that can interfere with testing for obstructive sleep apnea (OSA) including any benzodiazepine, barbiturate, general anesthesia, or conscious sedation within the prior 48 hours of the planned portable sleep apnea study 9. Anticipated inpatient rehabilitation length of stay \< 5 nights 10. Co-morbid conditions that limit OSA testing or CPAP use in the judgement of the study team 11. Recent cranial or spinal surgery with known or possible CSF leak or pneumocephalus within past 3 months 12. Patients at significant risk of aspiration that could render the patient at risk of harm from use of CPAP, in the opinion of the site PI.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute ischemic infarction are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cerebral infarction intracerebral hemorrhage ischemic stroke obstructive sleep apnea syndrome sleep apnea syndrome stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CPAP OSA - obstructive sleep apnea Stroke patients

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Rancho Research Institute

    RECRUITING

    Downey, California, 90242, United States

  • University of Washington - Harborview Medical Center

    RECRUITING

    Seattle, Washington, 98104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.